Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recovery Agitation after Administration of Ketadex, Ketofol and Ketamine
IRCT20190422043340N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ketamine, dexmedetomidine and propofol in Emergence agitation (EA) (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Recovery agitation. Started Jun 2019; status: completed.
02
Drugs
ketaminedexmedetomidinepropofol
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on IRCT20190422043340N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190422043340N1.